Takeda Mulls Bid for Shire to Create Global Drug Titan

0
1
Takeda Mulls Bid for Shire to Create Global Drug Titan

Takeda Pharmaceutical Co. said it was weighing a bid for rival Shire PLC, a potential deal that would create a global drug giant worth nearly $90 billion and mark the latest move in an industry brimming with deal activity.

Shares of London-listed Shire, the maker of drugs such as Adderall, for attention deficit hyperactivity disorder, soared more than 20% after the disclosure, boosting its market value to £33.2 billion, or about $47 billion—higher than Takeda’s $42 billion value at the close of Tokyo trading Wednesday.

Read More